Sygnature Discovery

News

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.